[
  {
    "ts": null,
    "headline": "Is Johnson & Johnson (JNJ) The Most Profitable Healthcare Stock To Buy?",
    "summary": "Johnson & Johnson (NYSE:JNJ) is among the most profitable healthcare stocks to buy. On January 22, TD Cowen lifted the price target on Johnson & Johnson (NYSE:JNJ) to $250, up from $222, and maintained a Buy rating, citing the company’s fourth quarter results. The revised price target reflects an upside potential of approximately 14%. According […]",
    "url": "https://finnhub.io/api/news?id=36cc9dd84b2983c43f501e2d49cce591e938e7ae38be949f5ba1d897d2996f0b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769880944,
      "headline": "Is Johnson & Johnson (JNJ) The Most Profitable Healthcare Stock To Buy?",
      "id": 138316638,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Johnson & Johnson (NYSE:JNJ) is among the most profitable healthcare stocks to buy. On January 22, TD Cowen lifted the price target on Johnson & Johnson (NYSE:JNJ) to $250, up from $222, and maintained a Buy rating, citing the company’s fourth quarter results. The revised price target reflects an upside potential of approximately 14%. According […]",
      "url": "https://finnhub.io/api/news?id=36cc9dd84b2983c43f501e2d49cce591e938e7ae38be949f5ba1d897d2996f0b"
    }
  },
  {
    "ts": null,
    "headline": "Jim Cramer GE Vernova Has “Visibility on the Earnings to the 2030s”",
    "summary": "GE Vernova Inc. (NYSE:GEV) is one of the stocks that Jim Cramer shared takes on, along with navigating market shortages. Cramer highlighted the company’s long-term prospects, as he said: We’re a nation short on power, too. For years, our electricity barely grew, so power generation became a tough business, bad business. Biggest company, General Electric, […]",
    "url": "https://finnhub.io/api/news?id=08b7add99bf296193cc1645caaacee175fc3b7a2098f110e633ccec3588b9902",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769867296,
      "headline": "Jim Cramer GE Vernova Has “Visibility on the Earnings to the 2030s”",
      "id": 138315120,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "GE Vernova Inc. (NYSE:GEV) is one of the stocks that Jim Cramer shared takes on, along with navigating market shortages. Cramer highlighted the company’s long-term prospects, as he said: We’re a nation short on power, too. For years, our electricity barely grew, so power generation became a tough business, bad business. Biggest company, General Electric, […]",
      "url": "https://finnhub.io/api/news?id=08b7add99bf296193cc1645caaacee175fc3b7a2098f110e633ccec3588b9902"
    }
  },
  {
    "ts": null,
    "headline": "The DGI Core Portfolio: 2025 Year-End Review",
    "summary": "The DGI Core Portfolio: 2025 Year-End Review",
    "url": "https://finnhub.io/api/news?id=e38a9974b47fdf124d7722526fb6b47b07c252956c3234c64c67d2b489b06471",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769847300,
      "headline": "The DGI Core Portfolio: 2025 Year-End Review",
      "id": 138314876,
      "image": "",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=e38a9974b47fdf124d7722526fb6b47b07c252956c3234c64c67d2b489b06471"
    }
  },
  {
    "ts": null,
    "headline": "Best Dividend Aristocrats For February 2026",
    "summary": "Dividend Aristocrats lagged the S&P 500 in 2025 but started 2026 strong.",
    "url": "https://finnhub.io/api/news?id=800289596e0fb58f29b2e1070377b29fa7b3a4d167bb115d6581677c59423fb0",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769833874,
      "headline": "Best Dividend Aristocrats For February 2026",
      "id": 138313889,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2249594654/image_2249594654.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "Dividend Aristocrats lagged the S&P 500 in 2025 but started 2026 strong.",
      "url": "https://finnhub.io/api/news?id=800289596e0fb58f29b2e1070377b29fa7b3a4d167bb115d6581677c59423fb0"
    }
  },
  {
    "ts": null,
    "headline": "This Top Dividend Stock Could Achieve a Major Milestone This Year. Is It a Buy?",
    "summary": "Johnson & Johnson is a picture of stability.",
    "url": "https://finnhub.io/api/news?id=54a37c1a00b8c95aff35856c5356803bc3cc187d6fa5e98da9a3e641687fdb6a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769830680,
      "headline": "This Top Dividend Stock Could Achieve a Major Milestone This Year. Is It a Buy?",
      "id": 138312569,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Johnson & Johnson is a picture of stability.",
      "url": "https://finnhub.io/api/news?id=54a37c1a00b8c95aff35856c5356803bc3cc187d6fa5e98da9a3e641687fdb6a"
    }
  }
]